230 related articles for article (PubMed ID: 6953260)
1. [Cefotetan, a new cephamycin antibiotic: in vitro and in vivo antibacterial activities (author's transl)].
Yano K; Suzaki K; Saito M; Toda M; Naito S; Ohmi Y
Jpn J Antibiot; 1982 Feb; 35(2):438-59. PubMed ID: 6953260
[TBL] [Abstract][Full Text] [Related]
2. [Experimental and clinical evaluation of cefotetan in pediatrics].
Toyonaga Y; Kurosu Y; Sugita M; Kita A; Yoshino N; Kouda N; Kumagai K; Horiuchi K; Hori M; Takahashi T
Jpn J Antibiot; 1983 Jun; 36(6):1243-60. PubMed ID: 6581330
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
Une T; Mitsuhashi S
Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
Tai M; Fukuoka Y; Yotsuji A; Kumano K; Takahata M; Mikami H; Yasuda T; Saikawa I; Mitsuhashi S
Antimicrob Agents Chemother; 1982 Nov; 22(5):728-34. PubMed ID: 6983861
[TBL] [Abstract][Full Text] [Related]
5. [Determination of the MIC of cefotetan against freshly isolated gram-negative bacilli].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1989 Nov; 42(11):2363-76. PubMed ID: 2621779
[TBL] [Abstract][Full Text] [Related]
6. Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics.
Russo G; Gismondo MR; Toscano MA; Speciale AM; Nicoletti G
J Antimicrob Chemother; 1983 Jan; 11 Suppl():79-85. PubMed ID: 6573327
[TBL] [Abstract][Full Text] [Related]
7. Cefotetan: profile of in-vitro activity.
Bauernfeind A
J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
[TBL] [Abstract][Full Text] [Related]
8. [Experimental and clinical evaluation of cefotetan in pediatrics].
Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Takagi M
Jpn J Antibiot; 1983 Jun; 36(6):1301-12. PubMed ID: 6581335
[TBL] [Abstract][Full Text] [Related]
9. [Experimental and clinical evaluation of cefotetan in pediatrics].
Iwata S; Iwasaki Y; Kanemitsu T; Tojo M; Jozaki K; Akita H; Kojima Y; Wakabayashi R; Sunakawa K; Osano M
Jpn J Antibiot; 1983 Jun; 36(6):1204-18. PubMed ID: 6581327
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of cefotetan in pediatrics].
Meguro H; Ozawa S; Togo T; Kim B; Arimasu O; Yonezawa H; Fujii R
Jpn J Antibiot; 1983 Jun; 36(6):1262-70. PubMed ID: 6581331
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of in vitro antibacterial activities of new cephems against clinical organisms (isolated between June 1983 and January 1984)].
Tsuji A; Goto S; Sato K; Tomizawa M; Hasebe S; Takagi T; Yatagai S; Kanno H; Ozaki K; Yakata M
Jpn J Antibiot; 1985 Aug; 38(8):2171-84. PubMed ID: 3908734
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
Daschner FD; Goerke C; Bassler M; Just M
Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
[TBL] [Abstract][Full Text] [Related]
13. [Experimental and clinical evaluation of a new cephamycin antibiotic, cefotetan, in pediatrics].
Nakazawa S; Sato H; Niino K; Suzuki H; Nakazawa S; Chikaoka H; Oka S; Hirama Y; Narita A
Jpn J Antibiot; 1983 Jun; 36(6):1219-32. PubMed ID: 6581328
[TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
[TBL] [Abstract][Full Text] [Related]
15. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Ward A; Richards DM
Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of cefotetan, other beta-lactams and netilmicin.
Shah PM
J Antimicrob Chemother; 1983 Jan; 11 Suppl():73-8. PubMed ID: 6573326
[TBL] [Abstract][Full Text] [Related]
17. Cefoxitin and cephamycins: microbiological studies.
Stapley EO; Birnbaum J; Miller AK; Wallick H; Hendlin D; Woodruff HB
Rev Infect Dis; 1979; 1(1):73-89. PubMed ID: 400941
[TBL] [Abstract][Full Text] [Related]
18. Cefotetan: comparative study in vitro against 226 Gram-negative clinical isolates.
Morel C; Vergnaud M; Langeard MM; Dupuy L
J Antimicrob Chemother; 1983 Jan; 11 Suppl():31-6. PubMed ID: 6573323
[TBL] [Abstract][Full Text] [Related]
19. Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.
Wallick H; Hendlin D
Antimicrob Agents Chemother; 1974 Jan; 5(1):25-32. PubMed ID: 4840447
[TBL] [Abstract][Full Text] [Related]
20. In-vitro antibacterial activity of cefotetan.
Grassi GG; Alesina R; Ferrara A; Peona V
J Antimicrob Chemother; 1983 Jan; 11 Suppl():45-58. PubMed ID: 6573325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]